Balaxi Pharma

Balaxi Pharmaceuticals Ltd Half Yearly Results

NSEBSE

₹58.37

(-3.15%)

Apr 25, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Sept-2024	Mar-2024	Sept-2023	Mar-2023	Sept-2022
Gross Sales	143	120.62	120.68	167.26	169.17
Excise Duty	0	0	0	0	0
Net Sales	143	120.62	120.68	167.26	169.17
Other Operating Income	0	0	0	0	0
Other Income	-5.96	-7.56	4.92	-4.79	7.42
Total Income	137.04	113.05	125.59	162.48	176.59
Total Expenditure	122.33	46.82	147.74	139.23	140.67
PBIDT	14.71	66.23	-22.15	23.25	35.93
Interest	0.82	1.02	0.66	0.28	0.22
PBDT	13.89	65.21	-22.8	22.97	35.71
Depreciation	0.95	1.15	0.95	1.37	0.38
Minority Interest Before NP	0	0	0	0	0
Tax	1.91	1.34	3.17	4.2	5.7
Deferred Tax	-0.04	-0.1	-0.01	1.07	0
Reported Profit After Tax	11.07	62.82	-26.91	16.33	29.63
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	11.07	62.82	-26.91	16.33	29.63
Extra-ordinary Items	0	41.02	-37.85	0	0
Adjusted Profit After Extra-ordinary item	11.07	21.8	10.94	16.33	29.63
EPS (Unit Curr.)	2.01	57.65	-26.33	16.04	29.63
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	0	0	0	0
Equity	11.04	10.9	10.23	10	10
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	10.28	54.9	-18.35	13.9	21.23
PBDTM(%)	-	-	-	-	-
PATM(%)	7.74	52.08	-22.29	9.76	17.51

No Record Found

Invest wise with Expert advice